Medi-Moses Group of Companies has successfully transformed plant-medicine research into 57 commercially viable herbal products over three decades. This indigenous firm exemplifies the Health Minister's call for Ghanaian researchers to move discoveries from laboratories to market.
Dr. De-Gaulle Moses Dogbatsey, CEO of Medi-Moses, has established a proven record in converting botanical research into practical herbal remedies. His work directly supports the health-sovereignty agenda outlined by Health Minister Kwabena Mintah Akandoh. The Minister emphasized that success in research would be measured by commercially viable products, not just grants awarded.
This initiative fits into Ghana's broader economic strategy to bolster national health security and reduce dependence on imported medicines. The COVID-19 pandemic highlighted the risks of relying on external supply chains for essential pharmaceuticals. Local production is now seen as crucial for retaining foreign exchange, creating jobs, and mitigating vulnerability to global supply shocks. The government aims to establish Ghana as a pharmaceutical hub for West Africa.
The Society of Private Medical and Dental Practitioners has endorsed this transition of research into patient care. Dr. Andre Kwesi Kumah, President of the Society, stated, “Strides made by Medi-Moses products in this area are therefore worthy of encouragement and support.” This endorsement underscores the medical community's recognition of local innovation.
The government plans a framework contract for medicines, estimated at GHS 159 million, to create a predictable market for quality local products. This commitment signals a significant shift towards supporting domestic pharmaceutical manufacturers. Decision-makers will closely monitor the implementation of this contract and its impact on local industry growth. Markets will respond to increased local production capacity and reduced import reliance.
Dr. Dogbatsey, a medical doctor with an MPhil in Pharmacognosy, specialized in plant medicine. He headed the Clinical Research Department at the Centre for Scientific Research into Plant Medicine from 2004 to 2008. His extensive background in both conventional and traditional medicine underpins Medi-Moses's research-driven approach. The company's flagship products, Prostacure Herbal Tea and Prostacure-X capsules, are recognized for treating enlarged prostate without surgery. These products are available across five branches nationwide.
Medi-Moses's portfolio addresses a wide range of conditions, including infertility, diabetes, hypertension, and malaria. These 57 products are direct outcomes of research translated into accessible medicines for ordinary Ghanaians. Industry observers note that Medi-Moses demonstrates the potential when research considers manufacturability, scalability, and patient affordability. The company's three-decade history proves that local capacity for pharmaceutical innovation already exists within the private sector. This success story provides practical evidence that research can move from the laboratory to the pharmacy shelf. It improves lives and strengthens national health security, aligning with Ghana's aspirations for self-sufficiency in medicine production. The focus on local production is expected to create numerous skilled jobs within the pharmaceutical sector. It will also reduce the outflow of foreign exchange previously spent on imported drugs. This strategic shift is vital for Ghana's long-term economic stability and public health resilience.